PubMed

Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution.

Giordano KF, Jatoi A, Adjei AA, Creagan ET, Croghan G, Frytak S, Jett JR, Marks R, Molina J, Okuno S, Richardson RL.

Lung Cancer. 2005 Aug;49(2):209-15. Epub 2005 Apr 13.PMID: 16022915 [PubMed - indexed for MEDLINE]Related articles

Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma.

Galanis E, Burch PA, Richardson RL, Lewis B, Pitot HC, Frytak S, Spier C, Akporiaye ET, Peethambaram PP, Kaur JS, Okuno SH, Unni KK, Rubin J.

Cancer. 2004 Dec 1;101(11):2557-66.PMID: 15517589 [PubMed - indexed for MEDLINE]Related articlesFree article

Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs.

Jatoi A, Kahanic SP, Frytak S, Schaefer P, Foote RL, Sloan J, Petersen RC.

Support Care Cancer. 2005 Jan;13(1):66-9. Epub 2004 Oct 9.PMID: 15480814 [PubMed - indexed for MEDLINE]Related articles

Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management.

Kanard A, Frytak S, Jatoi A.

J Support Oncol. 2004 Mar-Apr;2(2):127-32; discussion 133-5, 138-40. Review.PMID: 15328816 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of gemcitabine in advanced sarcomas.

Okuno S, Edmonson J, Mahoney M, Buckner JC, Frytak S, Galanis E.

Cancer. 2002 Jun 15;94(12):3225-9.PMID: 12115355 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term results of a phase I/II study of high-dose thoracic radiotherapy with concomitant cisplatin and etoposide in limited stage small-cell lung cancer.

Brown PD, Bonner JA, Foote RL, Frytak S, Marks RS, Richardson RL, Creagan ET.

Am J Clin Oncol. 2001 Dec;24(6):556-61.PMID: 11801753 [PubMed - indexed for MEDLINE]Related articles

Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy.

Galanis E, Frytak S, Rowland KM Jr, Sloan JA, Lennon VA.

Cancer Immunol Immunother. 1999 May-Jun;48(2-3):85-90.PMID: 10414461 [PubMed - indexed for MEDLINE]Related articles

Cerebral toxicity in patients treated for small cell carcinoma of the lung.

Fonseca R, O'Neill BP, Foote RL, Grill JP, Sloan JA, Frytak S.

Mayo Clin Proc. 1999 May;74(5):461-5.PMID: 10319075 [PubMed - indexed for MEDLINE]Related articles

Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.

Rajkumar SV, Frytak S, Rubin J, Camoriano JK, Fitch TR.

Am J Clin Oncol. 1997 Oct;20(5):500-4.PMID: 9345336 [PubMed - indexed for MEDLINE]Related articles

The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.

Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Trastek VF, Pairolero PC, Allen MS, Shaw EG, Marks RS, Frytak S, Lange CM, Li H.

Cancer. 1997 Oct 15;80(8):1399-408.PMID: 9338463 [PubMed - indexed for MEDLINE]Related articlesFree article

Mitomycin lung toxicity. Acute and chronic phases.

Okuno SH, Frytak S.

Am J Clin Oncol. 1997 Jun;20(3):282-4.PMID: 9167754 [PubMed - indexed for MEDLINE]Related articles

Extrapulmonary small cell carcinoma.

Galanis E, Frytak S, Lloyd RV.

Cancer. 1997 May 1;79(9):1729-36.PMID: 9128989 [PubMed - indexed for MEDLINE]Related articlesFree article

Survival of patients with extensive small-cell lung cancer who have only brain metastases at initial diagnosis.

Kochhar R, Frytak S, Shaw EG.

Am J Clin Oncol. 1997 Apr;20(2):125-7.PMID: 9124183 [PubMed - indexed for MEDLINE]Related articles

The case of the phantom bladder.

Fonseca R, Frytak S, Mokri B.

J Urol. 1997 Apr;157(4):1354. No abstract available. PMID: 9120942 [PubMed - indexed for MEDLINE]Related articles

Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer.

Frytak S, Shaw EG, Jett JR, Richardson RL, Foote RL, Creagan ET, Eagan RT, Su JQ.

Am J Clin Oncol. 1996 Apr;19(2):193-8.PMID: 8610649 [PubMed - indexed for MEDLINE]Related articles

Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung.

Shaw EG, Frytak S, Eagan RT, Richardson RL, Creagan ET, Jett JR, Foote RL, Su JQ, Schaid DJ, Lee RE.

Am J Clin Oncol. 1996 Apr;19(2):154-8.PMID: 8610640 [PubMed - indexed for MEDLINE]Related articles

Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancer.

Bonner JA, Eagan RT, Liengswangwong V, Frytak S, Shaw EG, Evans RG, Creagan ET, Richardson RL.

Cancer. 1995 Aug 1;76(3):406-12.PMID: 8625121 [PubMed - indexed for MEDLINE]Related articles

Prophylactic cranial irradiation in limited-stage small cell lung cancer.

Liengswangwong V, Bonner JA, Shaw EG, Foote RL, Frytak S, Richardson RL, Creagan ET, Eagan RT, Su JQ.

Cancer. 1995 Mar 15;75(6):1302-9.PMID: 7882280 [PubMed - indexed for MEDLINE]Related articles

Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant disease.

Call TG, Creagan ET, Frytak S, Buckner JC, van Haelst-Pisani C, Homburger HA, Katzmann JA.

Am J Clin Oncol. 1994 Aug;17(4):344-7.PMID: 8048398 [PubMed - indexed for MEDLINE]Related articles

Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy.

Liengswangwong V, Bonner JA, Shaw EG, Foote RL, Frytak S, Eagan RT, Jett JR, Richardson RL, Creagan ET, Su JQ.

J Clin Oncol. 1994 Mar;12(3):496-502.PMID: 8120547 [PubMed - indexed for MEDLINE]Related articles

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR.

J Clin Oncol. 1993 Jul;11(7):1269-75.PMID: 8315424 [PubMed - indexed for MEDLINE]Related articles

Role of radiation therapy in the management of lung cancer.

Shaw EG, Bonner JA, Foote RL, Martenson JA Jr, Frytak S, Deschamps C, McDougall JC.

Mayo Clin Proc. 1993 Jun;68(6):593-602. Review.PMID: 8388525 [PubMed - indexed for MEDLINE]Related articles

A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancer.

van Haelst-Pisani CM, Richardson RL, Su J, Buckner JC, Hahn RG, Frytak S, Kvols LK, Burch PA.

Cancer. 1992 Nov 1;70(9):2310-2.PMID: 1382829 [PubMed - indexed for MEDLINE]Related articles

Phase II evaluation of menogaril in patients with advanced hypernephroma.

Long HJ, Hauge MD, Therneau TM, Buckner JC, Frytak S, Hahn RG.

Invest New Drugs. 1991 Aug;9(3):261-2.PMID: 1838363 [PubMed - indexed for MEDLINE]Related articles

A technetium-labeled monoclonal antibody for imaging metastatic melanoma.

Frytak S, Creagan ET, Brown ML, Salk D, Nelp W.

Am J Clin Oncol. 1991 Apr;14(2):156-61.PMID: 2028923 [PubMed - indexed for MEDLINE]Related articles

Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigations.

Creagan ET, Schaid DJ, Ahmann DL, Frytak S.

J Invest Dermatol. 1990 Dec;95(6 Suppl):188S-192S.PMID: 2124246 [PubMed - indexed for MEDLINE]Related articles

Life-threatening bleomycin pulmonary toxicity with ultimate reversibility.

Hartmann LC, Frytak S, Richardson RL, Coles DT, Cupps RE.

Chest. 1990 Aug;98(2):497-9.PMID: 1695873 [PubMed - indexed for MEDLINE]Related articlesFree article

Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lung.

Robinow JS, Shaw EG, Eagan RT, Lee RE, Creagan ET, Frytak S, Richardson RL, Jett JR, Burton JK, Ilstrup DM.

Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1203-10.PMID: 2557304 [PubMed - indexed for MEDLINE]Related articles

Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant disease.

Creagan ET, Frytak S, Long HJ, Kvols LK.

Cancer. 1989 Sep 1;64(5):1034-7.PMID: 2474365 [PubMed - indexed for MEDLINE]Related articles

Cytogenetic studies in 11 patients with small cell carcinoma of the lung.

De Fusco PA, Frytak S, Dahl RJ, Weiland LH, Unni KK, Dewald GW.

Mayo Clin Proc. 1989 Feb;64(2):168-76.PMID: 2537918 [PubMed - indexed for MEDLINE]Related articles

Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation.

Frytak S, Shaw JN, O'Neill BP, Lee RE, Eagan RT, Shaw EG, Richardson RL, Coles DT, Jett JR.

Am J Clin Oncol. 1989 Feb;12(1):27-33.PMID: 2536214 [PubMed - indexed for MEDLINE]Related articles

A phase I clinical trial of recombinant human tumor necrosis factor.

Creagan ET, Kovach JS, Moertel CG, Frytak S, Kvols LK.

Cancer. 1988 Dec 15;62(12):2467-71.PMID: 3191449 [PubMed - indexed for MEDLINE]Related articles

Recombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term responders.

Creagan ET, Schaid DJ, Ahmann DL, Frytak S.

Am J Clin Oncol. 1988 Dec;11(6):652-9.PMID: 3142248 [PubMed - indexed for MEDLINE]Related articles

Necrotic lung and bronchopleural fistula as complications of therapy in lung cancer.

Frytak S, Lee RE, Pairolero PC, Arnold PG, Shaw JN.

Cancer Invest. 1988;6(2):139-43.PMID: 3378190 [PubMed - indexed for MEDLINE]Related articles

Treatment toxicities in long-term survivors of limited small cell lung cancer.

Frytak S, Shaw JN, Lee RE, Eagan RT, Shaw EG, Richardson RL, Creagan ET, Coles DT, Jett JR.

Cancer Invest. 1988;6(6):669-76.PMID: 2854492 [PubMed - indexed for MEDLINE]Related articles

Treatment of "limited" stage III non-small cell carcinoma of the lung.

Frytak S, Eagan RT, Sawamura K, Lee RE, Pairolero PC.

Cancer Invest. 1988;6(2):193-207. Review. No abstract available. PMID: 2837315 [PubMed - indexed for MEDLINE]Related articles

A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer.

Eagan RT, Frytak S, Richardson RL, Creagan ET, Therneau TM, Coles DT, Jett JR.

J Clin Oncol. 1988 Jan;6(1):5-8.PMID: 2826714 [PubMed - indexed for MEDLINE]Related articles

Recombinant leukocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinoma.

Creagan ET, Long HJ, Frytak S, Moertel CG.

Cancer. 1988 Jan 1;61(1):19-22.PMID: 2825959 [PubMed - indexed for MEDLINE]Related articles

Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma.

Creagan ET, Ahmann DL, Long HJ, Frytak S, Sherwin SA, Chang MN.

Cancer Treat Rep. 1987 Sep;71(9):843-4.PMID: 3113730 [PubMed - indexed for MEDLINE]Related articles

Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomas.

Edmonson JH, Long HJ, Frytak S, Smithson WA, Itri LM.

Cancer Treat Rep. 1987 Jul-Aug;71(7-8):747-8.PMID: 3038315 [PubMed - indexed for MEDLINE]Related articles

Delayed leukoencephalopathy in survivors with small cell lung cancer.

So NK, O'Neill BP, Frytak S, Eagan RT, Earnest F 4th, Lee RE.

Neurology. 1987 Jul;37(7):1198-201.PMID: 3037438 [PubMed - indexed for MEDLINE]Related articles

No routine role for vincristine, adriamycin, and cyclophosphamide (VAC) or thoracic radiation therapy in extensive stage small cell lung cancer.

Eagan RT, Frytak S, Lee RE, Therneau TM, Richardson RL, Creagan ET.

Am J Clin Oncol. 1987 Apr;10(2):141-5.PMID: 3031976 [PubMed - indexed for MEDLINE]Related articles

Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses.

Creagan ET, Ahmann DL, Frytak S, Long HJ, Chang MN, Itri LM.

Cancer. 1987 Feb 1;59(3 Suppl):638-46.PMID: 10822463 [PubMed - indexed for MEDLINE]Related articles

Phase II study of recombinant gamma-interferon in patients with advanced nonosseous sarcomas.

Edmonson JH, Long HJ, Creagan ET, Frytak S, Sherwin SA, Chang MN.

Cancer Treat Rep. 1987 Feb;71(2):211-3. No abstract available. PMID: 3100037 [PubMed - indexed for MEDLINE]Related articles

Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary report.

Frytak S, Eagan RT, Richardson RL, Creagan ET, Jett JL, Coles DT, Lee RE.

Am J Clin Oncol. 1987 Feb;10(1):33-5.PMID: 3030092 [PubMed - indexed for MEDLINE]Related articles

Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma. Analysis of complete and long-term responding patients.

Creagan ET, Ahmann DL, Frytak S, Long HJ, Itri LM.

Cancer. 1986 Dec 15;58(12):2576-8.PMID: 3779607 [PubMed - indexed for MEDLINE]Related articles

Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAP.

Eagan RT, Frytak S, Creagan ET, Richardson RL, Coles DT, Jett JR.

Am J Clin Oncol. 1986 Jun;9(3):249-54.PMID: 3755281 [PubMed - indexed for MEDLINE]Related articles

Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients.

Creagan ET, Ahmann DL, Frytak S, Long HJ, Chang MN, Itri LM.

Cancer Treat Rep. 1986 May;70(5):619-24.PMID: 3518925 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of diaziquone in malignant mesothelioma.

Eagan RT, Frytak S, Richardson RL, Creagan ET, Nichols WC.

Cancer Treat Rep. 1986 Mar;70(3):429. No abstract available. PMID: 3955559 [PubMed - indexed for MEDLINE]Related articles

Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancer.

Eagan RT, Frytak S, Richardson RL, Creagan ET, Nichols WC.

Am J Clin Oncol. 1986 Feb;9(1):67-70.PMID: 3082180 [PubMed - indexed for MEDLINE]Related articles